Skip to main content
. 2021 Mar 2;21:216. doi: 10.1186/s12885-021-07925-2

Table 2.

Postoperative complications in patients treated with/without prophylactic HIPEC

Control group (n = 17) Experimental group (n = 33) P value
Alb (< 35 g/L/≥35 g/L) 15/2 25/8 0.069
Change of tumor markers, Decrease/stable/increase 1/9/7 6/23/4 0.020
Median hospitalization day after surgery 10 (7–22) 11 (8–24) 0.255
Median drainage tube removal time after surgery 8 (6–17) 9 (5–24) 0.159
Anastomotic leakage/Intestinal leakage, Yes/No 1/16 4/29 0.490
Wound infection/Poor wound healing, Yes/No 0/17 0/33 1.000
Ileus, Yes/No 0/17 0/33 1.000
Leukopenia, None/grade I/II 13/2/2 25/6/2 0.956
Neutropenia, None/grade I/II 13/2/2 28/3/2 0.453
Liver dysfunction, None/grade I/II 4/10/3 10/15/8 0.773

Alb Albumin